PreveCeutical Medical Inc. (CSE:PREV)

Canada flag Canada · Delayed Price · Currency is CAD
0.0350
+0.0050 (16.67%)
Sep 19, 2025, 2:27 PM EDT
16.67%
Market Cap17.12M
Revenue (ttm)n/a
Net Income (ttm)-2.60M
Shares Out570.65M
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume265,571
Average Volume121,372
Open0.0300
Previous Close0.0300
Day's Range0.0300 - 0.0350
52-Week Range0.0150 - 0.0450
Beta0.19
RSI42.95
Earnings DateAug 29, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; and BSV Peptide Program that targets cancer progression. The company is headquartered in West Vancou... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Stephen Van Deventer
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PREV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.